Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel vs Paclitaxel + Cetuximab in Recurrent/Metastatic HNSCC (EXTAX)
NCT03887442Phase 2Terminated
- Start
- Feb 2011
- Primary completion
- Oct 2012
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of KL-140 in head and neck squamous cell carcinoma (HNSCC). Started Feb 2011; status: terminated.
02
Drugs
KL-140
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT03887442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03887442.